Conemphar SRL
3.4 FTEThe score of Conemphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +10 % Total assets +38 % Headcount (avg FTE) -24 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Conemphar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Jun 2026
- Year ended 31 Dec 2024filed on 19 Aug 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 07 Jul 2023
- Year ended 31 Dec 2021filed on 06 Jul 2022
Conemphar's financial analysis
- Solvency25.5%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Conemphar
Conemphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0478.091.521
- VAT number
- BE0478091521
- Peppol
- Registered · 0208:0478091521 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Jul 2002
- Registered office
- 7012 Mons
- Size
- Micro · 3.4 FTE
- Latest accounts
- 2025 · filed on 26 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Conemphar (SRL) has been based in Mons since 2002, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 9,547 € and equity of 347,199 €; its revenue is not published. With 3.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 25.5%, below the median of its sector (41.5%).
Companies similar to Conemphar
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Naegels-Jespers Retail sale of pharmaceutical products Bonheiden · balance sheet €1.36m
- Pharmacie DU Ballon Retail sale of pharmaceutical products Charleroi · balance sheet €1.36m
- Apothekers MARIABURG Ekeren Retail sale of pharmaceutical products Antwerp · balance sheet €1.35m
- Selfpharma Retail sale of pharmaceutical products Anderlecht · balance sheet €1.35m
- Lafaut Farma Retail sale of pharmaceutical products Bruges · balance sheet €1.38m
- PEP Pharma Retail sale of pharmaceutical products Pepinster · balance sheet €1.34m
- Centrumapotheek Vosselaar Retail sale of pharmaceutical products Vosselaar · balance sheet €1.34m
- Scarcez Retail sale of pharmaceutical products Mouscron · balance sheet €1.47m
Frequently asked questions about Conemphar
What is the revenue of Conemphar?
Conemphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Conemphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0478091521 for Conemphar, if the company is VAT-registered. Its company number (CBE) is 0478.091.521.
Where is the registered office of Conemphar?
According to the CBE register, the registered office of Conemphar is in 7012 Mons.
What is the equity of Conemphar?
At the close of the 2025 financial year, the equity of Conemphar amounts to 347,199 €, a solvency of 25.5% of total assets.
How many people work at Conemphar?
3.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Conemphar?
The register lists 1 active mandates at Conemphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Conemphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →